FOI release

Inspection Reports

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2025/00316

Received 26 March 2025

Published 30 May 2025

Request

Could you please share full latest WDA (GDP) & MS/GMP/MIA inspection report: (1) ACTIVE PHARMA SUPPLIES LIMITED, UNIT 2, FORWARD INDUSTRIAL ESTATE, TALBOT ROAD, LEYLAND, PR25 2ZJ, UNITED KINGDOM (2) ARC PHARMA (UK) LIMITED , UNIT 3, CURO PARK, FROGMORE, ST. ALBANS, AL2 2DD, UNITED KINGDOM (3) SYRI LIMITED, UNIT 4, BRADFIELD ROAD, RUISLIP, HA4 0NU, UNITED KINGDOM (4) VALNEVA SCOTLAND LIMITED, 1 OAKBANK PARK PLACE, MID CALDER, LIVINGSTON, EH53 0TN, UNITED KINGDOM (5) HAMOL LIMITED, NOTTINGHAM SITE, THANE ROAD, NOTTINGHAM, NG90 2DB, UNITED KINGDOM

Response

see attached

Documents

• FOI2025_00316 redacted for publication.pdf (103.9 KB)
• GMPInspectionReport_Syri Limited_redacted FINAL.pdf (441.8 KB)
• GMPReport_Active Pharma_redacted FINAL.pdf (543.3 KB)
• GMPReport_Arc Pharma_redacted FINAL.pdf (6.0 MB)
• GMPReport_Hamol_redacted FINAL.pdf (462.4 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.